Skip to main content
Top
Published in: Clinical Rheumatology 8/2020

01-08-2020 | Letters of Biomedical and Clinical Research

How should we overcome the threat by the pandemic of 2019-nCoV? Epidemic simulation using the SIRS model

Author: Jun Inamo

Published in: Clinical Rheumatology | Issue 8/2020

Login to get access

Excerpt

Since the first identification in December 2019 in Wuhan, China, a number of cases of novel coronavirus (2019-nCoV)-infected patients is increasing around the world. It has been reported that there are high-risk populations with high mortality, such as elderly people and those with comorbidities [1]. However, no specific treatment has been developed yet. Historically, humans have overcome the pandemics of viral infection by preventing secondary infection. Several studies have simulated the spread of 2019-nCoV, and the basic reproduction number (R0) ranges from 2.2 to 3.6 [2, 3]. On the other hand, patients treated with disease-modifying antirheumatic drugs may have insufficient antibody response, implying the possibility of reinfection [4]. …
Appendix
Available only for authorised users
Literature
2.
go back to reference Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D, Wang MH (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 92:214–217CrossRefPubMedPubMedCentral Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D, Wang MH (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 92:214–217CrossRefPubMedPubMedCentral
3.
go back to reference Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382:1199–1207. https://doi.org/10.1056/NEJMoa2001316CrossRefPubMedPubMedCentral Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382:1199–1207. https://​doi.​org/​10.​1056/​NEJMoa2001316CrossRefPubMedPubMedCentral
4.
go back to reference Hesselstrand R, Nagel J, Saxne T, Geborek P, Skattum L, Kapetanovic MC (2018) Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis. Rheumatology (Oxford) 57:625–630CrossRef Hesselstrand R, Nagel J, Saxne T, Geborek P, Skattum L, Kapetanovic MC (2018) Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis. Rheumatology (Oxford) 57:625–630CrossRef
Metadata
Title
How should we overcome the threat by the pandemic of 2019-nCoV? Epidemic simulation using the SIRS model
Author
Jun Inamo
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 8/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05083-7

Other articles of this Issue 8/2020

Clinical Rheumatology 8/2020 Go to the issue